Monthly evolution of the consumer price index and of the so-called health index, which is used for the price indexation of wages, social benefits and house-rent.

The 2019-2070 demographic outlook presents the evolution of the population and households in Belgium from 2019 to 2070.

The outlook also highlights the impact of alternative fertility scenarios on population growth. In the light of fertility trends and population ageing, it also confirms the key role of international migration in population growth.

PLANET is a model developed by the Belgian Federal PLANning Bureau that models the relationship between Economy and Transport. Its aim is to produce: (i) medium- and long-term projections of transport demand in Belgium, both for passenger and freight transport; (ii) simulations of the effects of transport policy measures; (iii) cost-benefit analyses of transport policy measures. This methodological report describes the main features of the PLANET model, and more specifically, the version 4.0 used for the transport outlook published in January 2019.

This paper presents an estimation of employment sustained directly and indirectly by exports based on an export-heterogeneous input-output table. In this table, manufacturing industries are disaggregated according to the exporter status of firms in order to account for within-industry differences in input structures. According to our results, export-sustained employment in Belgium amounted to 1.32 million jobs in 2010, which corresponds to 29.5 % of total employment.

In the size class “small”, BEV only have a lower TCO for an expected lifetime that exceeds most estimates of the planning horizon people use when purchasing cars. In the size class “medium”, BEVs have a lower TCO than conventional cars if their expected lifetime mileage is high enough. “Big” electric cars have higher TCO than their conventional counterparts for any reasonable assumption regarding their use profiles. 

The National Accounts Institute (NAI) presents in this publication a new version of the input-output tables at current prices for the year 2015, compiled according to the ESA 2010 methodology. Compared to the first version of the 2015 input-output tables published in December 2018, the tables presented here incorporate the occasional revision of the national accounts implemented by Belgium in 2019.

This paper describes the methodology to make the existing interregional supply and use table (ISUT) of 2010 compatible to ESA2010/SNA2008 rules and shows the results at a macro level. The ISUT describes, for each product and industry, all intra- and interregional flows caused by the intermediate use, final consumption expenditures, investments and exports of the three Belgian regions Brussels, Flanders and Wallonia.

This paper seeks to quantify the cost of the most important inefficiencies in Belgian transport taxation. To this end we calculate the welfare gain of an ideal, optimal tax/subsidy system across the transport market as a whole (i.e. considering private road traffic in conjunction with public transport). We found the total welfare gain to be 2.3 billion euros, of which 1.3 billion are due to time gains of remaining road users. Our measure lies significantly above those found in the literature, since we consider the distortion cause by a wide range of subsidies.

This Working Paper identifies the characteristics that explain severe material deprivation in Belgium, while making a distinction between people aged below 65 and those aged 65 or above. Severe material deprivation has decreased for both groups. Young people are more impacted than the elderly. Although there is a clear link between income and deprivation, the overlap between individuals identified as at risk of poverty and those as severely deprived is far from perfect. The correlation between income poverty and deprivation is weaker for the old group than for the young.

This Working Paper analyses the competitive position of the pharmaceutical industry over the 2000-2017 period. The evolution of price/cost competitiveness and non-cost competitiveness is studied based on a comparison with our neighbouring countries France, the Netherlands and Germany, and with Denmark, Ireland, Slovenia and Switzerland. The study also analyses a series of global factors and factors specific to the pharmaceutical industry that may influence competitiveness.

Belgium has committed to raise investment in research and development (R&D) to 3% of GDP by 2020. In fulfilment of this commitment, the federal government introduced different tax incentives in support of business R&D. This paper presents the results of the third evaluation of the efficiency of these tax incentives, covering the period 2003-2015.